Department of Experimental Medicine, Sapienza University of Rome, Italy.
Italian Institute of Scientific Sexology, Rome, Italy; Department of Biotechnological and Applied Clinical Sciences (DISCAB), University of L'Aquila, Italy.
Diabetes Res Clin Pract. 2020 Dec;170:108513. doi: 10.1016/j.diabres.2020.108513. Epub 2020 Oct 16.
To evaluate the effects of COVID-19 lockdown on blood glucose control in individuals with type 1 diabetes (T1D) and to explore determinants of glucose variability.
Fifty T1D patients undergoing continuous/flash glucose monitoring were recruited. The study's primary outcome was the change of time in range (TIR) from before to lockdown period. Three time-point comparisons of TIR, mean glucose levels (MG), estimated (e)HbA1c, time above (TAR) and below range (TBR), moderate/severe hypoglycemic events between pre-lockdown, lockdown and post-lockdown period were also performed. Information on lockdown-associated perceived stress, changes of work status and physical activity were recorded.
TIR significantly decreased (75(63-84)% vs.69(50-76)%,p < 0.001) whereas MG (154 ± 15 mg/dl vs.165 ± 25 mg/dl, p = 0.027) and eHbA1c (7.3(6.6-7.8)%vs.7.5(6.7-8.2)%,p = 0.031) increased from pre- to lockdown period; overall glucose control significantly improved when restriction ended. Lockdown-associated work loss/suspension independently predicted impaired TIR after adjustment for potential confounders (Standardizedβ: -0.29; 95%CΙ: -18.7 to -2.25;p = 0.01). Greater TAR, TBR and hypoglycemic events were also reported during the lockdown.
In T1D Italian individuals, blood glucose control significantly worsened during the COVID-19 lockdown; work instability and related issues represented the main determinant of impaired glucose variability in this population.
评估 COVID-19 封锁对 1 型糖尿病(T1D)患者血糖控制的影响,并探讨血糖变异性的决定因素。
招募了 50 名正在接受连续/闪光血糖监测的 T1D 患者。该研究的主要结果是从封锁前到封锁期间时间在目标范围内(TIR)的变化。还对 TIR、平均血糖水平(MG)、估计(e)HbA1c、高于(TAR)和低于(TBR)范围的时间、中度/重度低血糖事件在封锁前、封锁中和封锁后的三个时间点进行了比较。记录了与封锁相关的感知压力、工作状态和身体活动的变化。
TIR 显著降低(75(63-84)%比 69(50-76)%,p<0.001),而 MG(154±15mg/dl 比 165±25mg/dl,p=0.027)和 eHbA1c(7.3(6.6-7.8)%比 7.5(6.7-8.2)%,p=0.031)从封锁前到封锁期间增加;当限制结束时,整体血糖控制显著改善。在调整潜在混杂因素后,与封锁相关的工作损失/暂停独立预测 TIR 受损(标准化β:-0.29;95%CI:-18.7 至-2.25;p=0.01)。在封锁期间还报告了更大的 TAR、TBR 和低血糖事件。
在 T1D 意大利个体中,COVID-19 封锁期间血糖控制显著恶化;工作不稳定和相关问题是该人群血糖变异性受损的主要决定因素。